118 results
424B3
BXRXQ
Baudax Bio, Inc.
22 Nov 23
Prospectus supplement
4:58pm
financial statements is based upon the Baudax Bio, Inc. 2019 Equity Incentive Plan (the “Baudax Bio 2019 Plan”) and the TeraImmune 2019 Equity Incentive …
The Baudax Bio 2019 Equity Incentive Plan
BAUDAX BIO, INC.
Notes to the Consolidated Financial Statements
(amounts in thousands, except share and per share
PRER14A
m1mm6i t0ld
25 Aug 23
Preliminary revised proxy
4:01pm
DEFA14A
thl5y5nbbw
21 Aug 23
Additional proxy soliciting materials
8:05am
8-K
EX-10.1
v5enf0f83nko
21 Aug 23
Entry into a Material Definitive Agreement
8:00am
424B5
8mkysihtw
18 Aug 23
Prospectus supplement for primary offering
4:40pm
DEFA14A
9d0i ukk1o588zf
5 Jul 23
Additional proxy soliciting materials
5:28pm
8-K
EX-2.1
ken jdgg0wi
5 Jul 23
Entry into a Material Definitive Agreement
5:26pm
8-K
EX-99.1
4r4bcksgyl
28 Jun 23
Other Events
4:31pm
8-K
ihj7w09u
27 Jun 23
Submission of Matters to a Vote of Security Holders
4:05pm